Table 3.
Antibiotics Resistance | E. coli n = 31 | Klebsiella n = 4 | Pseudomonas n = 1 | Strep. pneum n = 4 |
Staph. areus n = 7 |
CONS, n = 13 |
Citrobacter n = 2 |
Acinetobacter n = 3 |
Enterobacter n = 2 |
Enterococcus n = 6 |
Strepviridans n = 4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Ampicillin | 22 (71%) | 4 (100%) | 0 | 2 (18%) | 2 (100%) | 2 (67%) | 1 (100%) | 3 (50) | 0 | ||
Cefuroxime | 16 (52%) | 2 (50%) | 0 | 1 (25%) | 2 (18%) | 1 (50%) | 2 (100%) | 2 (100%) | 0 | ||
Rocephin | 16 (52%) | 2 (50%) | 0 | 1 (20%) | 2 (18%) | 1 (50%) | 2 (100%) | 1 (50%) | 0 | ||
Ceftazidime | 16 (52%) | 2 (50%) | 0 | 0 | 1 (25%) | 2 (18%) | 0 (0%) | 3 (100%) | 2 (100%) | 0 | |
Gentamicin | 7 (23%) | 0 | 0 | 0 | 1 (14%) | 2 (17%) | 0 (0%) | 3 (100%) | 2 (100%) | 2 (40) | 0 |
Cotrimoxazole | 15 (48%) | 2 (50%) | 0 (0%) | 0 | 2 (17%) | 0 (0%) | 3 (100%) | 1 (50%) | 0 | ||
Amoxicillin/Clavulanic acid | 13 (42%) | 0 | 0 | 1 (25%) | 2 (18%) | 1 (50%) | 2 (100%) | 1 (50%) | 0 | 0 | |
Piperacillin | 15 (54%) | 1 (25%) | 0 | 0 | 1 (25%) | 2 (18%) | 0 (0%) | 3 (100%) | 1 (50%) | 0 | 0 |
Amikacin | 0 | 0 | 0 | 0 | 1 (25%) | 2 (18%) | 0 (0%) | 1 (50%) | 0 | 0 | 0 |
Ciprofloxacin | 15 (48%) | 0 | 0 | 0 (0%) | 3 (100%) | 1 (50%) | |||||
Meropenem | 0 | 0 | 0 | 0 | 1 (25%) | 2 (18%) | 0 (0%) | 3 (100%) | 0 | 0 | |
Piperacillin-Tazobactam | 1 (3.2%) | 0 | 0 | 0 | 2 (18%) | 0 (0%) | 3 (100%) | 1 (50%) | 0 | 0 | |
Tobramycin | 7 (25%) | 0 | 0 | 0 | 1 (25%) | 2 (18%) | 0 (0%) | 2 (100%) | 0 | 0 | 0 |
Vancomycin | 0 | 0 | 0 | 0 | 0 |